SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15572716
Source:
http://linkedlifedata.com/resource/pubmed/id/15572716
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013227
,
umls-concept:C0021149
,
umls-concept:C0030705
,
umls-concept:C0035410
,
umls-concept:C0332293
,
umls-concept:C0701159
pubmed:issue
21
pubmed:dateCreated
2004-12-1
pubmed:abstractText
Lipid-lowering agents are widely prescribed in the United States. Reliable estimates of rhabdomyolysis risk with various lipid-lowering agents are not available.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/FD-U-002067
,
http://linkedlifedata.com/resource/pubmed/grant/FD-U-002068
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15572716-15572723
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15572716-15784863
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7501160
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Clofibric Acid
,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1538-3598
pubmed:author
pubmed-author:AndradeSusan ESE
,
pubmed-author:ChanK ArnoldKA
,
pubmed-author:GoodmanMichael JMJ
,
pubmed-author:GrahamDavid JDJ
,
pubmed-author:GurwitzJerry HJH
,
pubmed-author:La GrenadeLoisL
,
pubmed-author:PlattRichardR
,
pubmed-author:SchechStephanie DSD
,
pubmed-author:ShatinDeborahD
,
pubmed-author:StaffaJudy AJA
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
292
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2585-90
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15572716-Clofibric Acid
,
pubmed-meshheading:15572716-Drug Therapy, Combination
,
pubmed-meshheading:15572716-Hospitalization
,
pubmed-meshheading:15572716-Humans
,
pubmed-meshheading:15572716-Hydroxymethylglutaryl-CoA Reductase Inhibitors
,
pubmed-meshheading:15572716-Hypolipidemic Agents
,
pubmed-meshheading:15572716-Incidence
,
pubmed-meshheading:15572716-Rhabdomyolysis
,
pubmed-meshheading:15572716-Risk
pubmed:year
2004
pubmed:articleTitle
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.
pubmed:affiliation
Office of of Drug Safety, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Md 20857, USA. grahamd@cder.fda.gov
pubmed:publicationType
Journal Article
,
Research Support, U.S. Gov't, P.H.S.